Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Tokyo  >  Mitsubishi Tanabe Pharma Corp    4508   JP3469000008

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Manufactures and distributes pharmaceuticals, pet products and medicines

Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products.

Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera.

The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan.
Sales per Businesses
20142015Delta
JPY (in Million)%JPY (in Million)%
Pharmaceuticals412,675100%415,124100% +0.59%
Sales per Regions
20142015Delta
JPY (in Million)%JPY (in Million)%
Japan353,30085.6%337,18081.2% -4.56%
Europe37,3489.1%48,61811.7% +30.18%
Asia15,9773.9%17,2454.2% +7.94%
North America5,6271.4%11,6962.8% +107.85%
Other423.000.1%385.000.1% -8.98%
Managers
NameAgeSinceTitle
Masayuki Mitsuka, PhD622007Executive President & Representative Director
Michihiro Tsuchiya, PhD691976Chairman
Eizou Tabaru582014Director, IR Contact, Manager-Finance & Accounting
Yoshiaki Ishizaki612007Director, Managing Executive Officer & GM-Sales
Seiichi Murakami591980Director & Head-External Affairs
Takashi Kobayashi611980Director, Managing Executive Officer & Head-Tokyo
Shigehiko Hattori752011Independent Director
Tsutomu Anno--Executive Officer & Deputy General Manager-Sales
Tetsuo Yoshikawa--Executive Officer & Manager-Kyushu Branch Sales
Shigeki Nakata--Executive Officer & Deputy General Manager-Sales
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 0.001 561,417,916 229,081,488 40.8% 428,945 0.1% 40.8%
Shareholders
NameEquities%
Mitsubishi Chemical Holdings Corp. 316,320,000 56.3%
Nippon Life Insurance Co. 12,065,000 2.15%
Mitsubishi UFJ Financial Group, Inc. 9,372,113 1.67%
BlackRock Fund Advisors 5,674,200 1.01%
Mitsubishi Tanabe Pharma Employee Stock Ownership Plan 4,317,000 0.77%
The Vanguard Group, Inc. 4,238,857 0.76%
Nipro Corp. 3,821,000 0.68%
Norges Bank Investment Management 3,615,547 0.64%
Tokio Marine Holdings, Inc. 3,132,900 0.56%
Nomura Asset Management Co., Ltd. 2,544,523 0.45%
Holdings
NameEquities%Valuation
SUZUKEN CO., LTD. (9987) 1,548,1921.50%54,548,950 USD
Alfresa Holdings Corporation (2784) 2,225,8120.95%43,835,542 USD
Medipal Holdings Corp (7459) 2,123,6360.87%34,409,317 USD
Nippon Shinyaku Co., Ltd. (4516) 519,0000.74%23,879,927 USD
VITAL KSK HOLDINGS INC (3151) 1,455,0002.38%12,531,551 USD
T&D Holdings Inc (8795) 1,144,8800.17%11,405,558 USD
Mitsubishi Tanabe Pharma Corp (4508) 428,6000.076%7,750,018 USD
Nichi-iko Pharmaceutical Co., Ltd. (4541) 250,0000.41%6,084,193 USD
TSURUHA HOLDINGS INC. (3391) 40,0000.082%3,890,936 USD
Iyo Bank Ltd (8385) 291,5660.090%1,965,977 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
ROCHE HOLDING LTD..
NOVARTIS AG
PFIZER INC.
MERCK & CO., INC.
BRISTOL-MYERS SQU..
NOVO NORDISK A/S
SANOFI
GLAXOSMITHKLINE P..
ALLERGAN PLC
ELI LILLY AND CO
BAYER AG
ASTRAZENECA PLC
ABBOTT LABORATORI..
TEVA PHARMACEUTIC..
-
SHIRE PLC
TAKEDA PHARMACEUT..
ASTELLAS PHARMA I..
MYLAN NV
SHIONOGI & CO LTD
Sector Pharmaceuticals
Mitsubishi Tanabe Pharma C : Connections
The Kaiteki Institute, Inc.
Meiji Yasuda Life Insurance Co.
Company contact information
Mitsubishi Tanabe Pharma Corp.
3-2-10 Dosho-machi
Chuo-Ku
Osaka 541-8505

Phone : +81.6.6205.5085
Fax : +81.6.6205.5262
Web : www.mt-pharma.co.jp
© 2016 People , Fundamentals and Ownership